The Pharmacy Compounding Foundation has elected five board members
APC has posted an updated version of our compilation of state by state adoption of USP <795>, <797>, and <800>.
We’ll let you read it for yourself. Interesting how the reporter seems to take Novo’s word for it, no?
A U.S. District Court judge approved APC filing an amicus brief this week in Novo Nordisk’s lawsuit against Tennessee compounder (and APC PFM) DCA Pharmacy.
One of the challenges of being an ambitious but resource-poor association is that we have to spend a lot of time asking members like you for money.
The photo inset below on the left was taken last Friday morning at Preston’s Pharmacy (a PFM, I might add) in Arlington, Virginia. It’s not a pharmacist or technician in the photo. It’s a healthcare reporter.
Patient safety is job one in any pharmacy, but especially in compounding pharmacies. So on those rare occasions when errors occur — in your pharmacy or someone else’s — you want to be able to learn from them.
In response to inquiries from state boards of pharmacy regarding the enforceability of revised USP Chapters <795>, <797>, and <800>, a recent memo aims to clarify references in the Food, Drug & Cosmetic Act.
Last week, we sent a letter to the California Board of Pharmacy requesting clarification of its position on compounding semaglutide.
APC is recruiting committee members for 2024.